| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- and ß-Chains1
*
Institut National de la Santé et de la Recherche Médicale, CJF 95-01, Institut Curie, Section Recherche, Paris, France; and
Consiglio Nazionale delle Ricerche, Center of Cellular and Molecular Pharmacology, Milan, Italy
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
- and
ß-chains. In contrast, the stability of the ß-peptide complexes
determined the efficiency of transport to the cell surface from
lysosomal, but not from endosomal, compartments. In murine B lymphoma
cells, SDS-unstable and -stable complexes were transported to the cell
surface at almost similar rates, whereas after lysosomal relocalization
or in a cell line in which MHC class II molecules normally accumulate
in lysosomal compartments, stable complexes were preferentially
addressed to the cell surface. Our results suggest that when peptide
loading occurs in lysosomal compartments, selective retention and
lysosomal degradation of unstable dimers result in the expression of
highly stable MHC class II-peptide complexes at the APC
surface. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
- and ß-chains) that
associate with antigenic peptides in compartments of the endocytic
pathway (1, 2). Therein, antigenic peptides are generated by partial
proteolysis of proteins endocytosed or phagocytosed by the APC (3). MHC
class II molecules are targeted to these compartments by a third
membrane protein, called the invariant chain
(Ii)3 (4). However, sequences
in the ß-chain lumenal domain also influence MHC class II transport
to endosomal compartments (5, 6). Once in endosomes, the Ii chain is
degraded, and a small Ii-derived peptide remains associated with the
ß dimer until it is exchanged for another peptide under the
control of a nonpolymorphic MHC class II molecule, HLA-DM (7). In the past few years, progress has been made toward defining the nature of the endocytic compartments where these events take place. In human EBV-transformed B cells (B-EBV) and melanoma cells, lysosomal compartments called MIICs (MHC class II compartment), constitute the main site of MHC class II-peptide association (8, 9, 10, 11). In LPS-stimulated murine B lymphocytes and certain B lymphoma cells, most compartments of the endocytic pathway, including early and late endosomes, as well as lysosomes contain MHC class II-peptide complexes (12, 13). In the mouse B lymphoma cell A20, an endosomal compartment called CIIV (class II vesicle), is the main peptide loading site for MHC class II dimers (14, 15, 16).
Invariant chain mediates MHC class II retention in endosomes (17) and determines their distribution between endosomes and lysosomes. In A20 cells, we have shown that a transient relocalization from endosomal to lysosomal compartments occurs when Ii chain degradation is blocked by the presence of the protease inhibitor, leupeptin (18). In the presence of leupeptin, MHC class II dimers remain associated with a partially degraded form of the invariant chain, Ii-p10, and are redistributed into lysosomes. Upon removal of the protease inhibitor, Ii-p10 is degraded, and peptide-loaded MHC class II molecules are delivered to the cell surface (18).
Interestingly, in mouse immature dendritic cells, MHC class II molecules bound to Ii-p10 accumulate in lysosomal compartments (19). Upon dendritic cell maturation, Ii-p10 is degraded, and MHC class II molecules move to endosomal CIIV, where they load antigenic peptides before reaching the plasma membrane (19). Therefore, depending on the species, the cell type, and even the stage of maturation, MHC class II molecules may traffick through endosomal and/or lysosomal compartments.
Whether from endosomal or lysosomal compartments, the pathway followed by MHC class II-peptide complexes to reach the cell surface is still unclear. Direct fusion of MIICs with the plasma membrane has been reported (20, 21), but the amount of MHC class II molecules thus delivered to the cell surface is likely to be very low (20). Recent results show that the route followed by MHC class II dimers from MIICs to the plasma membrane does not intersect recycling endosomes, and that it probably requires the formation of transport vesicles carrying the MHC class II-peptide complexes (22). Different routes are not mutually exclusive and could correspond to different origins of the compartments (endosomal or lysosomal) where the biogenesis of MHC class II molecules-peptide complexes occurs.
Intracellular trafficking of transmembrane proteins generally involves
recognition of signals in their cytosolic domains, by cytosolic factors
involved in the formation of transport vesicles. Thus, endosomal
targeting (and/or retention) signals in the cytosolic domain of the Ii
chain direct ßIi complexes from the trans-Golgi network
to endosomal compartments (23, 24, 25), either directly or after a brief
appearance at the plasma membrane (26, 27, 28). However, after Ii
degradation in endosomes and/or lysosomes, ß dimers are freed of
the transport signals of the Ii chain. This suggests the presence of a
signal responsible for transport of ß complexes from the
peptide-loading endocytic compartments to the plasma membrane. Such a
signal could lie in the cytosolic tails of the - or ß-chains,
which are known to contain signals for cell activation and
internalization (29, 30, 31).
Another factor that has been suggested to influence MHC class II transport to the plasma membrane is peptide association. It is known, indeed, that peptide loading correlates with the stabilization of the MHC class II dimers (32), preventing aggregation at acidic pH (33) and degradation (34, 35). An increase in the surface expression of MHC class II complexes after peptide loading has also been shown (36). However, the effect of the conformational modification caused by peptide loading on MHC class II intracellular transport has not been directly examined.
Here we have analyzed the influence of the structure and conformation
of MHC class II molecules on their transport from either endosomal or
lysosomal compartments to the cell surface. We found that the cytosolic
domains of MHC class II molecule - and ß-chains are dispensable
for the transport from both endosomal and lysosomal compartments. In
contrast, peptide loading determined efficient MHC class II transport
from lysosomal compartments to the plasma membrane, whereas it was not
required for transport from endosomes to the plasma membrane.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
A variant of the A20 murine B lymphoma cell line that has lost Fc receptor expression (IIA1.6) (37) was used to generate the cell lines used here. It was cultured in RPMI medium supplemented with glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 µg/ml), pyruvate (1 mM), ß-ME (50 µM), and 5% FCS (Sigma, St. Quentin, France). Stable cell lines expressing transfected I-Ab molecules were grown in the same medium supplemented with 0.5 mg/ml each of G418 (Life Technologies, Cergy, France) and hygromycin (Boehringer Mannheim, Meylan, France). The D1 dendritic cell line has been described previously (38): it was cultured in Iscove’s modified Dulbecco’s medium (Sigma) supplemented with glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 µg/ml), ß-ME (50 µM), 10% LPS-free FCS (Life Technologies), and 30% granulocyte-macrophage CSF-expressing NIH-T3 cell-conditioned medium. The Abs used here were mouse anti-mouse I-Ab mAb Y3P and rat anti-mouse lamp-1 mAb (PharMingen, San Diego, CA).
Generation of cells expressing truncated MHC class II molecules
The cDNAs encoding truncated forms of the and ß
I-Ab chains were generated by PCR using, respectively, a
plasmid encoding the full-length I-Ab (provided by Dr.
R. Germain, National Institutes of Health, Bethesda, MD) and cDNAs made
from the I-Ab-transfected T1 cell line (provided by Dr. N.
Braunstein, Columbia University, New York, NY) as matrix, and the
following primers: 5'-TCTTCTCGAGCAGGATGCCGCGCAGCAGAGC-3'
(I-Ab 5'),
5'-TCTTGATATCATCTAGAGCCTTGAATGATGAAGATGG-3' (I-Ab
3'), 5'-TCTTCTCGAGAGATGGCTCTGCAGATCCCC-3' (I-Ab ß
5'), and 5'-TCTTGATATCATCTAGAGAAAAGGCCAAGCCCGAGG-3'
(I-Ab ß 3').
EcoRV- and XhoI-digested PCR products were cloned
downstream of a SR promoter (39) in expression vectors carrying
resistance genes for hygromycin B (NTH2, I-Ab-
) and
neomycin (NTNeo, I-Ab-ß) and were fully sequenced. The
full-length I-Ab - and ß-encoding cDNAs (respectively,
provided by Dr. R. Germain, National Institutes of Health, and Drs.
Avie Barlow and Charles Janeway, Yale University, New Haven, CT) were
subcloned in the same NTH2 (I-Ab-) and NTNeo
(I-Ab-ß) vectors.
IIA1.6 cells were electroporated (260 V, 975 µF) with 50 µg of each
linearized plasmid (NTH2-I-Ab- or - and
NTNeo-I-Ab-ß or -ß). Three days after
electroporation, cells were switched to selection medium (normal medium
supplemented with 10% FCS and 1 mg/ml each of G418 and hygromycin) and
semisubcloned at 1.5 x 104 cells/16-mm well. Growing
cells were analyzed for surface I-Ab expression by FACScan
after Y3P Ab staining.
Cells expressing high levels of surface I-Ab were subcloned
by limiting dilution in 96-well plates. Cells expressing the
ß-transfected molecules at their surface were more difficult
to obtain than cells of any of the other combinations (only 30% of the
ß clones were positive for I-Ab surface
expression, whereas for each of the other three combinations, at least
50% of the clones were positive).
Pulse-chase labeling, cell surface biotinylation, and immunoprecipitation
Experiments were performed as previously described (14, 18). Briefly, cells metabolically labeled for 20 min with [35S]methionine/cysteine (1 mCi/ml; Amersham, Les Ulis, France) were chased for various periods of time at 37°C with normal culture medium. When added (in the reversibility experiments), leupeptin (Sigma) was used at 2 mM in 2% FCS-supplemented medium. At the end of the chase, cells were biotinylated for 2 min with NHS-SS-biotin (Pierce, Rockford, IL; 2 mg/ml in PBS at 4°C) and lysed in 0.5% Triton X-100-containing buffer. I-Ab class II molecules were precipitated with Y3P-coated protein A-Sepharose beads (Pharmacia, Saclay, France) for 1 to 2 h at 4°C and then eluted from the beads for 5 min at 95°C in 100 µl of PBS-2% SDS. To analyze SDS-stable MHC class II dimers, this latter step was conducted for 30 to 60 min at room temperature (nonboiled conditions). Ten microliters was kept for subsequent SDS-PAGE analysis (total molecules), and 89 µl was incubated with streptavidin-agarose beads (Pierce) in 1 ml of PBS-2% Triton X-100 for 2 h at 4°C, to precipitate the biotinylated fraction of the I-Ab class II molecules (surface molecules). After washing, precipitated molecules were eluted from the beads in 15 µl of 125 µM DTT-containing SDS-PAGE sample buffer at 95°C for 5 min (or at room temperature for 30–60 min for the SDS-stable dimers experiments) before being analyzed on 12% polyacrylamide SDS gels.
Quantification was conducted either with the ImageQuant software on a Molecular Dynamics PhosphorImager (Sunnyvale, CA) or with Bio-1D software (Vilber-Lourmat, Marne la Vallée, France) after scanning the autoradiographs with a camera (Bio-print system, Vilber-Lourmat). In experiments performed according to the reversibility protocol, the I-Ab molecules newly arrived at the cell surface were estimated by correcting the values at the different chase times with the value of I-Ab molecules expressed at the cell surface at time zero.
Immunofluorescence microscopy
Immunofluorescence was performed as previously described (37). Cells were allowed to adhere to a poly-L-lysine-coated glass coverslip for 30 min at room temperature and then fixed in 3% paraformaldehyde in PBS for 20 min, permeabilized in 0.05% saponin, and incubated with primary Abs (Y3P, biotinylated Y3P, or anti-lamp-1) diluted in 0.05% saponin-0.2% BSA-PBS for 30 min at room temperature. For D1 cells, this step was performed after a 30-min preincubation in 2.4G2 (rat anti-mouse Fc receptor) supernatant. After washing, cells were incubated with FITC- or TRITC-conjugated streptavidin or F(ab')2 of donkey anti-mouse or donkey anti-rat Abs (Pierce). Cells were mounted in Mowiol and analyzed using a TCS scanning laser confocal microscope (Leica Microscopy and Scientific Instruments, Heerbrugg, Switzerland).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
To test the possibility that transport of MHC class II molecules
from endocytic compartments to the plasma membrane may require signals
present in the - or ß-chain cytosolic domains, we generated cDNAs
encoding truncated forms of the murine I-Ab - and/or
ß-chains, called, respectively, and ß, in which the
entire cytosolic domains were deleted (Fig. 1
A). The four possible
combinations of the full-length and truncated - and ß-chains were
transfected into the IIA1.6 murine B lymphoma cell line, a variant of
the A20 cell line (37) expressing endogenous MHC class II
I-Ad molecules. Since previous reports have shown that the
steady state surface expression of truncated MHC class II molecules is
similar to that of full-length molecules (40), we decided to select,
for each combination, at least two independent clones expressing
similar levels of the transfected I-Ab molecules at their
surface (Fig. 1B).
|
ß dimers from
the four types of metabolically labeled cell lines, we tested whether
the transfected molecules are of the sizes expected for full-length and
truncated molecules (Fig. 1
C). In all the experiments
performed, the signal obtained with the ß clones was weaker
than that with the ß, ß, and ß cells, suggesting
that acquisition of the mature conformation recognized by the Y3P Ab is
impaired by the double truncation of and ß cytosolic domains.
This experiment shows that the transfected I-Ab - and
ß-chains do not detectably form heterodimers with the endogenous
I-Ad chains; in truncated (or ß)-chain-expressing
cells, immunoprecipitation with the I-Ab specific Ab (Y3P)
does not coprecipitate the endogenous full-length I-Ad, as
shown by the sole presence of a band corresponding to the truncated
(ß)-chains after SDS-PAGE analysis (Fig. 1C). The A20 B lymphoma cell line as a dual model for studying MHC class II transport from endosomal and lysosomal compartments to the cell surface
The cell lines generated were then used to analyze the transport
of full-length and truncated ß dimers from either endosomal or
lysosomal compartments to the cell surface. In a previous study, we
described in the A20 murine B lymphoma cell line the endosomal
compartments in which MHC class II molecules accumulate before
associating with antigenic peptides (14, 15). In these cells, MHC class
II do not transit through lysosomes, indicating that peptide loading
takes place exclusively in endosomal compartments. However, upon
leupeptin treatment of I-Ab-expressing A20 cells, newly
synthesized MHC class II molecules remained associated with Ii-p10 and
relocalized to lysosomal compartments (18). This relocalization was
reversible; when leupeptin was washed out, Ii-p10 degradation was
completed and MHC class II molecules appeared at the plasma membrane
(18). Here, we have used this experimental system to study MHC class II
trafficking from either endosomal (in untreated cells) or lysosomal
compartments (in leupeptin-exposed cells, reversibility experiments) to
the plasma membrane, using metabolically labeled and surface
biotinylated cells as previously described (14, 15, 18) (Fig. 2).
|
If the cytosolic domain of MHC class II molecules is important for
their transport from the endocytic pathway to the cell surface, then
the kinetics of plasma membrane delivery of full-length and truncated
molecules should be different. We therefore conducted experiments
according to the first protocol described in Figure 2 on the ß,
ß, and ß clones. After pulse labeling, chase, and
surface biotinylation of the cells, mature I-Ab dimers were
precipitated with Y3P Ab, and the biotinylated fraction of these
molecules was reprecipitated with streptavidin-agarose. In these
conditions, the streptavidin-precipitated material represents
exclusively cell surface-expressed molecules as evidenced by 1) the
absence of precipitation of internal molecules such as Ii, and 2) the
absence of precipitation of I-Ab dimers if the
biotinylation step is omitted (data not shown) (14, 15, 18).
In all three cell types, the mature dimers began to form about 1 h
after the pulse, and they reached the plasma membrane 30 to 60 min
later (Fig. 3A).
Interestingly, no delay was observed in the arrival at the surface of
either of the truncated dimers. Even in the double mutant ß,
the few mature dimers that formed were transported normally to the
plasma membrane (not shown). Therefore, MHC class II transport from
endosomes to the plasma membrane is independent of the cytosolic
domains of the - and ß-chains.
|
, we first checked that
the truncated molecules were relocalized to lysosomal compartments as
efficiently as full-length I-Ab in the presence of
leupeptin. Figure 3B shows immunofluorescent staining of
I-Ab molecules in a ß-expressing clone in control
conditions (Fig. 3B, upper panels) or after
4 h in the presence of 2 mM leupeptin (Fig. 3B,lower panels). The transfected I-Ab molecules are
mainly localized at the plasma membrane in cells cultured in control
conditions, with little intracellular staining and no colocalization
with the lysosomal marker, lamp-1 (Fig. 3B). We have
previously shown that the low levels of intracellular class II
molecules are due to the rapid kinetics of transport through endosomal
CIIV in these cells (14, 18). In contrast, in the presence of
leupeptin, most of the I-Ab molecules relocalized to
intracellular lamp-1-containing compartments (Fig. 3B).
Similar results were obtained with the ß-, ß-, and
ß-expressing clones (data not shown); they are consistent
with our published results obtained using the B4-14 clone (18).
Approximately 80% of the newly synthesized class II molecules were
found in lysosomes under these conditions (18).
In pulse-chase reversibility experiments, the ß molecules that had
accumulated in lysosomes started to reach the plasma membrane about 2
to 4 h (average timing obtained in two different clones) after
leupeptin removal (Fig. 3C), and the surface signal reached
a plateau between 8 and 20 h of chase. Similar results were
obtained with the ß-, the ß-, and the
ß-expressing cell lines (Fig. 3C and data not
shown). The kinetics obtained were thus similar to those described for
the B4-14 cell line. Therefore, transport of I-Ab molecules
from either endosomal or lysosomal compartments to the cell surface
does not require the cytosolic tail of - or ß-chains.
Selective transport of SDS-stable I-Ab complexes from lysosomal compartments to the plasma membrane
Besides Ii chain degradation, which could unveil a signal in the
- or ß-chain cytosolic domain, the other critical event that could
influence MHC class II transport to the cell surface is peptide
loading. We next investigated whether peptide binding could influence
I-Ab transport from endosomal and lysosomal compartments to
the plasma membrane. A conformational modification of MHC class II
molecules upon peptide binding has been described previously (32);
ß dimers become stable in the presence of SDS at room temperature
and migrate as a 50- to 60-kDa band on SDS gels, instead of the two 32-
to 28-kDa bands observed for unstable ß dimers, or upon boiling of
the samples.
We used the protocols described in Figure 2 to compare the surface
delivery of newly synthesized SDS-stable and -unstable MHC class II
dimers in the I-Ab ß-expressing B lymphoma cell line.
To analyze both SDS-stable and -unstable I-Ab dimers,
Y3P-precipitated molecules were eluted from protein A-Sepharose beads
in SDS at room temperature, instead of at 95°C. After
streptavidin-agarose precipitation of the biotinylated fraction of
I-Ab dimers, precipitated molecules were eluted from the
beads at room temperature in the presence of DTT (125 µM) to cleave
the disulfide bound between biotin and cell surface proteins. Both
samples (total and surface MHC class II molecules) were then analyzed
by SDS-PAGE.
As shown in Figure 4A, in untreated cells
(protocol 1, Fig. 2) both stable (compact, C) and unstable (U) ß
dimers reached the cell surface (Surface) with similar efficiencies;
the ratios of compact to unstable molecules were comparable in the
total and surface samples. Indeed, quantification of the ratios between
surface-expressed and total I-Ab molecules shows that
compact dimers are transported to the plasma membrane only slightly
more efficiently than the unstable ones. In four independent
experiments, the rate of SDS-stable dimer arrival at the surface,
defined by the surface-expressed/total molecules ratio as a function of
time, is not significantly different from that of the SDS-unstable
dimer arrival at the surface (Fig. 4B). Therefore, the
efficiencies of transport of SDS-stable and SDS-unstable complexes are
similar under conditions where MHC class II molecules transit through
endosomes.
|
C), whereas the remaining unstable dimers never
reached the cell surface even though they were not associated with
Ii-p10 anymore (no Ii-p10 is coprecipitated by the Y3P Ab after 8
h in the absence of leupeptin, see Figs. 4C and
3C). Therefore, after lysosomal relocalization of newly
synthesized MHC class II molecules, in the presence of leupeptin,
SDS-stable dimers were very efficiently delivered to the cell surface,
whereas unstable dimers were barely detectable there.
Quantification of four different experiments shows that under these
conditions, compact dimers are transported to the plasma membrane 10
times more efficiently than unstable dimers (Fig. 4D). Since
compact forms of I-Ab dimers result from a stable MHC class
II dimer-peptide association, our results indicate that transport of
peptide-loaded I-Ab molecules from lysosomal compartments
to the cell surface is more efficient than transport of empty and/or
unstable molecules. In contrast, transport from endosomal compartments
to the plasma membrane does not significantly discriminate between
SDS-stable and -unstable dimers.
Selective transport of SDS-stable I-Ab complexes in murine dendritic cells
As our results were obtained in cells in which MHC class II
molecules had been artificially relocalized to lysosomes by leupeptin
exposure, we investigated whether the transport of SDS-stable
I-Ab complexes in cells in which MHC class II molecules
normally accumulate in lysosomal compartments was also selective. We
chose the I-Ab-expressing murine D1 dendritic cell line
(38), which shows all the characteristics of immature murine dendritic
cells. Figure 5A shows the
intracellular localization of I-Ab molecules in the
immature D1 cells; MHC class II molecules are mainly concentrated in
intracellular compartments containing the lamp-1 lysosomal marker as
well as H2-M (not shown).
|
ß dimer formation and surface delivery were not different
from those observed for the B lymphoma cell line; mature dimers
appeared after 1 h of chase and reached the plasma membrane 30 to
60 min later (Fig. 5B). In this respect, D1 cells behave
more like human immature dendritic cells (41) than like freshly
explanted mouse immature dendritic cells, in which newly synthesized
MHC class II molecules are retained in lysosomal compartments and never
reach the cell surface (19).
However, strikingly, SDS-stable complexes were much more efficiently
transported to the cell surface than the unstable ones.
Quantification (Fig. 5C) of four independent experiments
gave a slope of the surface delivery curve 4 times higher for the
stable than for the unstable ß mature complexes. These results
show that in a cell line in which MHC class II molecules traffick
through lysosomal compartments, peptide-bound ß dimers are more
efficiently conveyed to the plasma membrane than unstable
molecules.
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The idea that stable peptide loading (or at least SDS-stability) influences MHC class II surface expression has previously been proposed (33, 36). Germain’s group has shown that incubation of B lymphoma cells with a peptide that stably associates with MHC class II molecules induces an increase in the overall levels of class II expression at the cell surface (33). The same group showed that stable peptide loading on purified class II molecules induced their stabilization, preventing aggregation at acidic pH, and proposed that this stabilization determines their transport out of the endocytic compartments where peptide loading takes place (36). However, no experimental evidence supporting this possibility in terms of cell biology was provided.
We now show that the origin of the endocytic compartments, endosomal or
lysosomal, is determinant for transport of the loaded class II
molecules to the cell surface. The selectivity in transport to the cell
surface of SDS-stable class II molecules most likely results from a
selective retention of unstable complexes in lysosomes. Association to
the Ii chain fragment Ii-p10 is known to cause MHC class II retention
in lysosomal compartments (17, 18). However, selective retention of
unstable dimers cannot be imputable exclusively to Ii-p10, since the Ii
fragment was completely degraded after 4 to 6 h of reversibility,
a time when abundant unstable class II molecules were still retained
intracellularly (Fig. 4C), and most SDS-stable dimers were
already at the cell surface.
It is most likely, as previously suggested, that in the acidic environment of lysosomes, unstable class II molecules unfold and aggregate, perhaps with putative lysosomal chaperons, which cause their retention and subsequent degradation. Indeed, we observed a selective degradation of unstable dimers, although the percentage of molecules degraded during the time of our assay did not exceed 20 to 30%. It has also been previously reported that stable peptide binding prevents MHC class II degradation both in vitro and in vivo (34, 35).
However, because the pathways for MHC class II transport to the surface are still poorly understood, the actual mechanisms underlying the retention of SDS-unstable dimers in lysosomes are difficult to understand. Two different mechanisms of MHC class II transport to the plasma membrane have been suggested: direct fusion of the entire MHC class II-containing compartments with the plasma membrane (20, 21), and formation of transport vesicles containing the peptide-MHC class II complexes, targeted, directly or not, to the plasma membrane (22). In their recent work, Pond and Watts (22) show that brefeldin A inhibits the addressing of SDS-stable MHC class II molecules to the plasma membrane, supporting the involvement of vesicle budding in this process.
In contrast, we found that transport to the plasma membrane was not
affected by truncation of the - and ß-chain cytosolic domains,
suggesting that if vesicle budding is required for transport from the
endocytic pathway to the cell surface, sorting of MHC class II into
these vesicles is independent of their cytosolic domain. It is known
that the cytosolic domain of the transferrin receptor is not required
for its recycling from endosomes to the cell surface (42). It is
therefore not surprising that transport of MHC class II molecules from
endosomal compartments to the cell surface does not depend on their
cytosolic domain. However, a requirement of these domains for transport
from lysosomes to the cell surface would have been expected, since
transport from these compartments to the plasma membrane is in general
very inefficient. Our results, therefore, suggest that a constitutive
transport pathway of membrane proteins from lysosomes to the cell
surface exists, and that lysosomal localization requires retention or
internalization and lysosomal targeting signals.
We also confirmed results obtained previously with another MHC class II
molecule (40): namely, a negative effect of both - and ß-chain
truncation on the efficiency of MHC class II - and ß-chain
conversion to mature dimers (in our work, recognized by the Y3P Ab).
These results suggest that the truncated - and ß-chains do not
fold properly, causing their retention and degradation in the
endoplasmic reticulum, as previously suggested (40).
Finally, what could be the biologic relevance of a selective retention of unstable MHC class II dimers in lysosomal, but not endosomal, compartments? The nature of the peptide-loading compartment on MHC class II has been a matter of controversy for the past few years. However, it appears that MHC class II molecules may transit through different endocytic compartments (43), and although this has not been formally demonstrated, it seems likely that peptide loading occurs all along the endocytic pathway.
From early endosomes to lysosomes, the luminal milieu of the compartments changes, becoming increasingly acidic and acquiring more active proteolytic enzymes. This is thought to be correlated with a difference in the antigenic peptides generated in these various compartments, since the most accessible parts of the proteins might give rise to peptides in endosomal compartments, whereas the deeper (i.e., more protected) parts of Ags would need to reach lysosomes to be degraded. A difference in the types of peptides generated in endosomal vs lysosomal compartments has actually been shown recently (44).
The overall expected effect of the preferential retention of unstable peptide-loaded MHC class II molecules in lysosomes is the selection of more stable peptide-MHC class II complexes displayed at the cell surface, as loading occurs in later endocytic compartments. It is also important to consider that in physiologic situations, APC internalize Ags through specific membrane receptors: surface Ig in B lymphocytes and mannose receptors or Fc receptors in monocytes and dendritic cells. It is expected that the higher the affinity of the receptors for the internalized Ags, the longer lasting will be their association during endocytic transport, and the more efficiently will Ags be delivered to lysosomal compartments (as pH drops, low affinity interactions could be disrupted before transport to lysosomes). In vivo, as the Ab B cell response develops, Abs with increasing affinity for the Ag are produced. Therefore, B cells, through their surface Ig, and dendritic cells and monocytes, through their Fc receptors, internalize increasingly stable Ag-Ab complexes. If it were functional in vivo, the selective retention of unstable MHC class II dimers in lysosomal compartments would therefore result in the selection of increasingly stable peptide-MHC class II complexes for expression at the APC surface, as the affinities of the specific Abs produced increase.
|
Acknowledgments |
|---|
- and ß-chains, respectively; N. Braunstein
for the I-Ab-expressing T1 cell line; P. Benaroch and
I. Mellman for critical reading of the manuscript; and
D. Meur for photography. |
Footnotes |
|---|
2 Address all correspondence and reprints requests to Dr. S. Amigorena, CJF 95-01, Institut Curie, 12 rue Lhomond, 75005 Paris, France. E-mail address:
3 Abbreviations used in this paper: Ii, invariant chain; MIIC, MHC class II compartment; CIIV, class II vesicle.
Received for publication January 8, 1998. Accepted for publication April 16, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and Ig ß subunits in MHC class II-restricted antigen presentation. Immunity 3:335.[Medline]
promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466.This article has been cited by other articles:
|
|
 |
|
  Y. Kuwano, C. M. Prazma, N. Yazawa, R. Watanabe, N. Ishiura, A. Kumanogoh, H. Okochi, K. Tamaki, M. Fujimoto, and T. F. Tedder CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells Int. Immunol., August 1, 2007; 19(8): 977 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Khalil, A. Brunet, and J. Thibodeau A three-amino-acid-long HLA-DR{beta} cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35 J. Cell Sci., October 15, 2005; 118(20): 4679 - 4687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Shumilla, V. Lacaille, T. M. C. Hornell, J. Huang, S. Narasimhan, D. A. Relman, and E. D. Mellins Bordetella pertussis Infection of Primary Human Monocytes Alters HLA-DR Expression Infect. Immun., March 1, 2004; 72(3): 1450 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Gregers, B. Fleckenstein, F. Vartdal, P. Roepstorff, O. Bakke, and I. Sandlie MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation Int. Immunol., November 1, 2003; 15(11): 1291 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Khalil, A. Brunet, I. Saba, R. Terra, R. P. Sekaly, and J. Thibodeau The MHC class II {beta} chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal Int. Immunol., October 1, 2003; 15(10): 1249 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kleijmeer, G. Ramm, D. Schuurhuis, J. Griffith, M. Rescigno, P. Ricciardi-Castagnoli, A. Y. Rudensky, F. Ossendorp, C. J.M. Melief, W. Stoorvogel, et al. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells J. Cell Biol., October 1, 2001; 155(1): 53 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Ramm, L Pond, C Watts, and W Stoorvogel Clathrin-coated lattices and buds on MHC class II compartments do not selectively recruit mature MHC-II J. Cell Sci., January 1, 2000; 113(2): 303 - 313. [Abstract] [PDF]
|
|
|
|
|
|
C. Driessen, R. A.R. Bryant, A.-M. Lennon-Dumenil, J. A. Villadangos, P. W. Bryant, G.-P. Shi, H. A. Chapman, and H. L. Ploegh Cathepsin S Controls the Trafficking and Maturation of MHC Class II Molecules in Dendritic Cells J. Cell Biol., November 15, 1999; 147(4): 775 - 790. [Abstract] [F |
